No Increase in All-Cause Mortality at 2 Years Among Patients Undergoing Drug-Coated Balloon Angioplasty

Drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) became an area of intense debate following a 2018 meta-analysis by Katsanos et al. ([1][1]), who reported increased all-cause mortality at 2 years among patients treated with DCBs versus conventional PTA. Although there remain